Insulin Glargine Injection 100 IU/mL

πŸ”Ή Insulin Glargine Injection 100 IU/mL – As Licensed


πŸ“„ Description:

Insulin Glargine is a long-acting recombinant human insulin analogue, used to provide basal (background) insulin coverage. It is a clear solution given once daily to maintain consistent blood glucose levels in patients with Type 1 and Type 2 diabetes mellitus.


πŸ’Š Prescription / Use:

  • Indications:
    • Type 1 Diabetes Mellitus (used with short-acting insulin)
    • Type 2 Diabetes Mellitus (when oral drugs are insufficient)
    • Adults, adolescents, and children (β‰₯6 years)
  • Form & Strength:
    • Injection: 100 IU/mL
    • Available as 10 mL vials, 3 mL cartridges, or pre-filled pens (SoloStar)
  • Route:
    • Subcutaneous only (SC)
    • Not for IV or IM use
  • Dosing:
    • Once daily, same time every day
    • Individualized based on patient’s glucose profile

πŸ”¬ Nature:

  • Recombinant DNA insulin analogue
  • Modified to form microprecipitates in subcutaneous tissue β†’ slow, steady absorption
  • Clear, colorless solution (unlike NPH, which is cloudy)
  • Onset: ~1.5 hours
  • No pronounced peak
  • Duration: ~24 hours (can vary 20–30 hrs)

🌟 Advantages:

  • Once-daily dosing simplifies regimen
  • Mimics natural basal insulin more closely
  • Stable glucose levels with minimal fluctuations
  • Lower risk of nocturnal hypoglycemia
  • Useful in intensive insulin therapy

πŸ“¦ Common Packaging:

  • 3 mL prefilled pens (SoloStar, Basaglar, Lantus, etc.)
  • 10 mL vial (1000 IU total) for use with insulin syringes
  • Clearly labeled with:
    • Drug name: Insulin Glargine 100 IU/mL
    • Strength, expiry, storage info, batch number

🧊 Storage:

  • Store refrigerated at 2Β°C–8Β°C
  • Do not freeze
  • After opening:
    • Can be stored at room temperature <25Β°C for up to 28 days
  • Keep away from direct sunlight and heat

⚠️ Precautions:

  • Do NOT mix with other insulins (destroys long-acting properties)
  • Do NOT administer IV (risk of hypoglycemia)
  • Monitor for hypoglycemia, especially during dose adjustments
  • Use correct technique with pen or syringe
  • Rotate injection sites to prevent lipodystrophy

πŸ‘©β€βš•οΈ Patient Advice:

  • Inject once daily, same time each day
  • Use new needle each time with pen or syringe
  • Do not skip meals or delay after insulin injection
  • Watch for symptoms of low blood sugar (sweating, dizziness, confusion)
  • Carry a sugar source (like glucose tablets or candy)
  • Keep insulin pen/cap closed when not in use
  • Discard opened vials or pens after 28 days, even if insulin remains

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button